UpdatesCompany Update

The company has announced a board meeting on Monday, November 13, 2023. The agenda includes approving the financial results for the quarter and half-year.

Welcure Drugs & Pharmaceuticals Ltd524661 · Filed with the exchange

The Board will also consider a fundraising proposal, potentially through a Preferential Issue of Warrants convertible into Equity Shares.

Other methods like a Rights Issue, Qualified Institutions Placement (QIP), or Private Placement may also be explored.

Additionally, the meeting will discuss the appointment of an Independent Director and a Chief Financial Officer, signaling key leadership changes.

Read the original filing(PDF)

No comments yet. Be the first.

More from Welcure Drugs & Pharmaceuticals Ltd

All announcements